LONA

LeonaBio, Inc.

7.56 USD

Last updated Sep 4, 20:46 UTC

Yesterday HIGH

$8.07

Yesterday LOW

$7.54

52w HIGH

$14.19

52w LOW

$3.52

EPS

-0.80

PE

-9.45

Next Earnings

Nov 5, 2026

Overview News Government Trades Fundamentals

LeonaBio, Inc. stock is down -1.56% since 30 days ago. The next earnings date is Nov 5, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 20% of the previous 6 September’s closed higher than August. 100% of analysts rate it a buy.

Benzinga Newsdesk

Wed Aug 19, 2026

Mizuho Maintains Outperform on LeonaBio, Lowers Price Target to $15

Mizuho analyst Graig Suvannavejh maintains LeonaBio (NASDAQ:LONA) with a Outperform and lowers the price target from $16 to $15.
Benzinga Newsdesk

Mon Aug 17, 2026

Citizens Maintains Market Outperform on LeonaBio, Lowers Price Target to $17

Citizens analyst Jason N. Butler maintains LeonaBio (NASDAQ:LONA) with a Market Outperform and lowers the price target from $18 to $17.
Benzinga Newsdesk

Fri Aug 14, 2026

LeonaBio Q2 EPS $(0.80) Beats $(1.36) Estimate

LeonaBio (NASDAQ:LONA) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(1.36) by 41.18 percent. This is a 55.56 percent increase over losses of $(1.80) per share from the
Benzinga Newsdesk

Wed Aug 12, 2026

LeonaBio’s Lead Product Candidate, Lasofoxifene, To Be Featured In Multiple Presentations At Dava Oncology’s 4th Summit On Breast Cancer

LeonaBio, Inc. (NASDAQ:LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that its lead product candidate,
Benzinga Newsdesk

Thu Jul 30, 2026

Citizens Upgrades LeonaBio to Market Outperform, Announces $18 Price Target

Citizens analyst Jason N. Butler upgrades LeonaBio (NASDAQ:LONA) from Market Perform to Market Outperform and announces $18 price target.
Benzinga Insights

Mon Jun 22, 2026

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Tenon Medical (NASDAQ:TNON) shares increased by 115.8% to $0.76 during Monday's pre-market session. The company's market cap stands at $4.0 million. Aditxt (NASDAQ:ADTX) shares rose 84.99% to $0.02.
Benzinga Insights

Wed Jun 17, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Newsdesk

Wed May 27, 2026

Piper Sandler Initiates Coverage On LeonaBio with Overweight Rating, Announces Price Target of $20

Piper Sandler analyst Kelsey Goodwin initiates coverage on LeonaBio (NASDAQ:LONA) with a Overweight rating and announces Price Target of $20.
Benzinga Newsdesk

Thu May 7, 2026

LeonaBio Q1 EPS $(1.73) Beats $(2.50) Estimate

LeonaBio (NASDAQ:LONA) reported quarterly losses of $(1.73) per share which beat the analyst consensus estimate of $(2.50) by 30.8 percent. This is a 26.07 percent increase over losses of $(2.34) per share from the same
Benzinga Insights

Wed Apr 8, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session

Mizuho

Wed Aug 19, 19:56

buy

confirm
Citizens

Mon Aug 17, 14:55

buy

confirm